Gene · 5607
Papers1,405
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,405
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics and Epigenetics in Obesity: What Do We Know so Far? | Curr Obes Rep | 2023 | 37819541 | PubTator, text mining | PubMed |
| Advances in the regulation of adipogenesis and lipid metabolism by exosomal ncRNAs and their role in related metabolic diseases. | Front Cell Dev Biol | 2023 | 37791070 | PubTator, text mining | PubMed |
| Negr1-Derived Peptides Trigger ALK Degradation and Halt Neuroblastoma Progression In Vitro and In Vivo. | Pharmaceutics | 2023 | 37765276 | PubTator, text mining | PubMed |
| How does NFAT3 regulate the occurrence of cardiac hypertrophy? | Int J Cardiol Heart Vasc | 2023 | 37753338 | PubTator, text mining | PubMed |
| Iterative machine learning-based chemical similarity search to identify novel chemical inhibitors. | J Cheminform | 2023 | 37742003 | PubTator, text mining | PubMed |
| Interaction between genetic susceptibility to obesity and food intake on BMI in Finnish school-aged children. | Sci Rep | 2023 | 37709841 | PubTator, text mining | PubMed |
| Dietary approach to stop hypertension and healthy eating index 2015, modify the association between FTO polymorphisms and obesity phenotypes. | BMC Res Notes | 2023 | 37697388 | PubTator, text mining | PubMed |
| IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway. | Cancers (Basel) | 2023 | 37686528 | PubTator, text mining | PubMed |
| Biological functions and research progress of eIF4E. | Front Oncol | 2023 | 37601696 | PubTator, text mining | PubMed |
| The significance of ERK5 catalytic-independent functions in disease pathways. | Front Cell Dev Biol | 2023 | 37601096 | PubTator, text mining | PubMed |
| TRAF7 is an essential regulator of blood vessel integrity during mouse embryonic and neonatal development. | iScience | 2023 | 37583551 | PubTator, text mining | PubMed |
| Anticancer pan-ErbB inhibitors reduce inflammation and tissue injury and exert broad-spectrum antiviral effects. | J Clin Invest | 2023 | 37581931 | PubTator, text mining | PubMed |
| CMGC Kinases in Health and Cancer. | Cancers (Basel) | 2023 | 37568654 | PubTator, text mining | PubMed |
| Resolving the role of podoplanin in the motility of papillary thyroid carcinoma-derived cells using RNA sequencing. | Comput Struct Biotechnol J | 2023 | 37560122 | PubTator, text mining | PubMed |
| Investigating pathogenic SNP of PKCι in HCV-induced hepatocellular carcinoma. | Sci Rep | 2023 | 37532886 | PubTator, text mining | PubMed |
| Methionine restriction and cancer treatment: a systems biology study of yeast to investigate the possible key players. | Turk J Biol | 2023 | 37529420 | PubTator, text mining | PubMed |
| Identification of a Novel ERK5 (MAPK7) Inhibitor, MHJ-627, and Verification of Its Potent Anticancer Efficacy in Cervical Cancer HeLa Cells. | Curr Issues Mol Biol | 2023 | 37504304 | PubTator, text mining | PubMed |
| Orchestrating smart therapeutics to achieve optimal treatment in small cell lung cancer: recent progress and future directions. | J Transl Med | 2023 | 37452395 | PubTator, text mining | PubMed |
| The Microenvironment of the Pathogenesis of Cardiac Hypertrophy. | Cells | 2023 | 37443814 | PubTator, text mining | PubMed |
| Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications. | Cells | 2023 | 37443746 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5607/papers?page=5